Jeffrey Ryan Stewart, EVP, Chief Commercial Officer at AbbVie Inc. (ABBV), sold 57,469 shares at $149.04 ($8.5M) on 2022-03-01, disclosed to the SEC on 2022-03-01.
Seasonal sale ($8.5M) by EVP, Chief Commercial Officer — this insider has traded ABBV in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $149.54 | 17,093 | $2.6M | 29.9% |
| 2 | $147.43 | 6,229 | $918K | 10.8% |
| 3 | $147.43 | 6,229 | $918K | 10.8% |
| 4 | $148.49 | 12,659 | $1.9M | 22.0% |
| 5 | $148.49 | 12,659 | $1.9M | 22.0% |
| 6 | $149.04 | 2,600 |
| $388K |
| 4.5% |
| Total | $148.60 avg | 57,469 | $8.5M | 100% |
| Filing → |
| ABBV | SELL | 2023-03-15 | $16.2M | — | Filing → |
| ABBV | SELL | 2022-03-25 | $4.4M | — | Filing → |
| ABBV | SELL | 2021-12-17 | $275K | — | Filing → |